329 research outputs found
Tempering Romance
The Fabulous Dark Cloister: Romance in England after the Reformation by Tiffany Jo Werth. Baltimore, MD: Johns Hopkins University Press, 2011. Pp. 248, 8 illustrations. $65.00 cloth
Female Sexual Function Index Short Version: A MsFLASH Item Response Analysis
The Female Sexual Function Index (FSFI) is a psychometrically sound and popular 19-item self-report measure, but its length may preclude its use in studies with multiple outcome measures, especially when sexual function is not a primary endpoint. Only one attempt has been made to create a shorter scale, resulting in the Italian FSFI-6, later translated into Spanish and Korean without further psychometric analysis. Our study evaluated whether a subset of items on the 19-item English-language FSFI would perform as well as the full-length FSFI in peri- and post-menopausal women. We used baseline data from 898 peri- and post-menopausal women recruited from multiple communities, ages 42–62 years, and enrolled in randomized controlled trials for vasomotor symptom management. Goals were to (1) create a psychometrically sound, shorter version of the FSFI for use in peri- and post-menopausal women as a continuous measure and (2) compare it to the Italian FSFI-6. Results indicated that a 9-item scale provided more information than the FSFI-6 across a spectrum of sexual functioning, was able to capture sample variability, and showed sufficient range without floor or ceiling effects. All but one of the items from the Italian 6-item version were included in the 9-item version. Most omitted FSFI items focused on frequency of events or experiences. When assessment of sexual function is a secondary endpoint and subject burden related to questionnaire length is a priority, the 9-item FSFI may provide important information about sexual function in English-speaking peri- and post-menopausal women
Spectroscopy of Globular Clusters out to Large Radius in the Sombrero Galaxy
We present new velocities for 62 globular clusters in M104 (NGC 4594, the
Sombrero Galaxy), 56 from 2dF on the AAT and 6 from Hydra on WIYN. Combined
with previous data, we have a total sample of 108 M104 globular cluster
velocities, extending to 20 arcmin radius (~60 kpc), along with BVR photometry
for each of these. We use this wide-field dataset to study the globular cluster
kinematics and dark matter content of M104 out to 10 arcmin radius (30 kpc). We
find no rotation in the globular cluster system. The edge-on nature of M104
makes it unlikely that there is strong rotation which is face-on and hence
unobserved; thus, the absence of rotation over our large radial range appears
to be an intrinsic feature of the globular cluster system in M104. We discuss
ways to explain this low rotation, including the possibility that angular
momentum has been transferred to even larger radii through galaxy mergers. The
cluster velocity dispersion is ~230 km/s within several arcmin of the galaxy
center, and drops to ~150 km/s at ~10 arcmin radius. We derive the mass profile
of M104 using our velocity dispersion profile, together with the Jeans equation
under the assumptions of spherical symmetry and isotropy, and find excellent
agreement with the mass inferred from the stellar and gas rotation curve within
3 arcmin radius. The M/L_V increases from ~4 near the galaxy center to ~17 at 7
arcmin radius (~20 kpc, or 4 R_e), thus giving strong support for the presence
of a dark matter halo in M104. More globular cluster velocities at larger radii
are needed to further study the low rotation in the globular cluster system,
and to see if the dark matter halo in M104 extends beyond a radius of 30 kpc.Comment: 40 pages, 7 figures, accepted for publication in Ap
Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
INTRODUCTION: Viral suppression prevents HIV transmission and disease progression, but socio-economic and clinical factors can hinder the goal of suppression. We evaluated factors associated with viral non suppression (VNS) and persistent viremia (PV) in people living with HIV (PLHIV) receiving antiretroviral therapy (ART) in Guatemala.
METHODS: We conducted a cross sectional analysis using data from an ongoing cohort of PLHIV attending the largest HIV clinic in Guatemala. Univariable and multivariable analyses were conducted between PLHIV with viral suppression and detectable viremia. VNS was defined as most recent HIV RNA ≥ 200 copies/ml and PV as two consecutive HIV RNA ≥ 200 copies/ml.
RESULTS: Of 664 participants, 13.3% had VNS and 7.1% had PV. In univariable analysis disaggregated by gender, low income, poor education, perceived difficulty attending healthcare, and alcohol use were associated with VNS in men while low CD4 at diagnosis, multiple prior ART regimens and treatment interruptions were significant in both genders. Multiple prior ART regimens (adjusted Odds Ratio (aOR) 2.82, [95% confidence interval (CI) 1.59, 4.99], p \u3c 0.01), treatment interruptions (aOR 4.51, [95% CI 2.13, 9.58], p \u3c 0.01), excessive alcohol consumption (aOR 2.56, [95% CI 1.18, 5.54], p \u3c 0.05) perceived difficulty attending healthcare (aOR 2.07, [ 95% CI 1.25, 3.42], p \u3c 0.01) and low CD4 at diagnosis (aOR 2.34, 95% [CI 1.30, 4.20], p \u3c 0.01) were independently associated with VNS on multivariable regression.
CONCLUSIONS: We conclude that socio-economic and clinical factors influence viral suppression in our cohort and vary between men and women. Gender specific approaches are necessary to achieve the 90% suppression goal
Efficacy of yoga for vasomotor symptoms: a randomized controlled trial
OBJECTIVE: This study aims to determine the efficacy of yoga in alleviating vasomotor symptoms (VMS) frequency and bother.
METHODS: This study was a three-by-two factorial, randomized controlled trial. Eligible women were randomized to yoga (n = 107), exercise (n = 106), or usual activity (n = 142), and were simultaneously randomized to a double-blind comparison of ω-3 fatty acid (n = 177) or placebo (n = 178) capsules. Yoga intervention consisted of 12 weekly 90-minute yoga classes with daily home practice. Primary outcomes were VMS frequency and bother assessed by daily diaries at baseline, 6 weeks, and 12 weeks. Secondary outcomes included insomnia symptoms (Insomnia Severity Index) at baseline and 12 weeks.
RESULTS: Among 249 randomized women, 237 (95%) completed 12-week assessments. The mean baseline VMS frequency was 7.4 per day (95% CI, 6.6 to 8.1) in the yoga group and 8.0 per day (95% CI, 7.3 to 8.7) in the usual activity group. Intent-to-treat analyses included all participants with response data (n = 237). There was no difference between intervention groups in the change in VMS frequency from baseline to 6 and 12 weeks (mean difference [yoga--usual activity] from baseline at 6 wk, -0.3 [95% CI, -1.1 to 0.5]; mean difference [yoga--usual activity] from baseline at 12 wk, -0.3 [95% CI, -1.2 to 0.6]; P = 0.119 across both time points). Results were similar for VMS bother. At week 12, yoga was associated with an improvement in insomnia symptoms (mean difference [yoga - usual activity] in the change in Insomnia Severity Index, 1.3 [95% CI, -2.5 to -0.1]; P = 0.007).
CONCLUSIONS: Among healthy women, 12 weeks of yoga class plus home practice, compared with usual activity, do not improve VMS frequency or bother but reduce insomnia symptoms
Menopausal Quality of Life: A RCT of Yoga, Exercise and Omega-3 Supplements
Objective—
Determine efficacy of three non-hormonal therapies for improving menopause-
related quality of life (QOL) in women with vasomotor symptoms (VMS).
Methods—
12-week 3×2 randomized, controlled, factorial design trial. Peri- and postmenopausal
women, ages 40-62 years, were randomized to yoga (n=107), exercise (n=106), or usual activity
(n=142), and also randomized to double-blind comparison of omega-3 (n=177) or placebo (n=178)
capsules. Interventions: 1) weekly 90-minute yoga classes with daily at-home practice; 2)
individualized facility-based aerobic exercise training 3 times/week; and 3) 0.615 gram omega-3
supplement, 3 times/day. Outcomes: Menopausal Quality of Life Questionnaire (MENQOL) total
and domain (VMS, psychosocial, physical and sexual) scores.
Results—
Among 355 randomized women, average age 54.7 years, 338 (95%) completed 12-
week assessments. Mean baseline VMS frequency was 7.6/day and mean baseline total MENQOL
score was 3.8 (range 1-8 from better to worse) with no between-group differences. For yoga
compared to usual activity, baseline to 12-week improvements were seen for MENQOL total -0.3
(95% CI -0.6 to 0.0, p=0.02), and VMS (p=0.02) and sexuality (p=0.03) domain scores. For
exercise and omega-3 compared to controls, improvements in baseline to 12-week total MENQOL
scores were not observed. Exercise showed benefit in the MENQOL physical domain score at 12-
weeks (p=0.02).
Conclusion—
All women become menopausal and many seek medical advice on ways to
improve quality of life; little evidence-based information exists. We found, among healthy
sedentary menopausal women, yoga appears to improve menopausal QOL - the clinical
significance of our finding is uncertain due to modest effect
Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers
Resistance to oestrogen-deprivation therapy is common in oestrogen-receptor-positive (ER+) breast cancer. To better understand the contributions of tumour heterogeneity and evolution to resistance, here we perform comprehensive genomic characterization of 22 primary tumours sampled before and after 4 months of neoadjuvant aromatase inhibitor (NAI) treatment. Comparing whole-genome sequencing of tumour/normal pairs from the two time points, with coincident tumour RNA sequencing, reveals widespread spatial and temporal heterogeneity, with marked remodelling of the clonal landscape in response to NAI. Two cases have genomic evidence of two independent tumours, most obviously an ER− ‘collision tumour', which was only detected after NAI treatment of baseline ER+ disease. Many mutations are newly detected or enriched post treatment, including two ligand-binding domain mutations in ESR1. The observed clonal complexity of the ER+ breast cancer genome suggests that precision medicine approaches based on genomic analysis of a single specimen are likely insufficient to capture all clinically significant information
Uncovering the Genetic Architecture of Seed Weight and Size in Intermediate Wheatgrass through Linkage and Association Mapping
Intermediate wheatgrass [IWG; Thinopyrum intermedium (Host) Barkworth & D.R. Dewey subsp. intermedium] is being developed as a new perennial grain crop that has a large allohexaploid genome similar to that of wheat (Triticum aestivum L.). Breeding for increased seed weight is one of the primary goals for improving grain yield of IWG. As a new crop, however, the genetic architecture of seed weight and size has not been characterized, and selective breeding of IWG may be more intricate than wheat because of its self-incompatible mating system and perennial growth habit. Here, seed weight, seed area size, seed width, and seed length were evaluated across multiple years, in a heterogeneous breeding population comprised of 1126 genets and two clonally replicated biparental populations comprised of 172 and 265 genets. Among 10,171 DNA markers discovered using genotyping-by-sequencing (GBS) in the breeding population, 4731 markers were present in a consensus genetic map previously constructed using seven full-sib populations. Thirty-three quantitative trait loci (QTL) associated with seed weight and size were identified using association mapping (AM), of which 23 were verified using linkage mapping in the biparental populations. About 37.6% of seed weight variation in the breeding population was explained by 15 QTL, 12 of which also contributed to either seed length or seed width. When performing either phenotypic selection or genomic selection for seed weight, we observed the frequency of favorable QTL alleles were increased to \u3e46%. Thus, by combining AM and genomic selection, we can effectively select the favorable QTL alleles for seed weight and size in IWG breeding populations
- …